{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:11:59Z","timestamp":1701821519923},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.2967\/jnmt.123.265655","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:55:31Z","timestamp":1694530531000},"page":"318-322","source":"Crossref","is-referenced-by-count":0,"title":["Imaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma"],"prefix":"10.2967","volume":"51","author":[{"given":"Stephen","family":"Edmonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanne","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusudan","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"2023120505300846000_51.4.318.1","unstructured":"Pizzo PA Poplack DG . Principles and Practice of Pediatric Oncology. 7th ed. Wolters Kluwer; 2015:3."},{"key":"2023120505300846000_51.4.318.2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-018-4181-2","article-title":"Pheochromocytoma and paraganglioma: an update on diagnosis, evaluation, and management","volume":"35","author":"Jain","year":"2020","journal-title":"Pediatr Nephrol."},{"key":"2023120505300846000_51.4.318.3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180151"},{"key":"2023120505300846000_51.4.318.4","unstructured":"Phaeochromocytoma & paraganglioma structured reporting protocol. Royal College of Pathologists of Australasia website. https:\/\/www.rcpa.edu.au\/getattachment\/f80e5699-a23e-49fb-a41a-8c2b7c8380a3\/Endocrine-Phaeochromocytoma.aspx. Published 2020. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.5","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2020.18794"},{"key":"2023120505300846000_51.4.318.6","unstructured":"Louis DN Ohgaki H Wiestler OD Cavenee WK . WHO Classification of Tumours of the Central Nervous System. 4th ed. International Agency for Research on Cancer; 2016:164."},{"key":"2023120505300846000_51.4.318.7","unstructured":"A5 SDHB genomics study. University of Melbourne website. https:\/\/medicine.unimelb.edu.au\/research-groups\/clinical-pathology-research\/rare-disease-oncogenomics\/a5-sdhb-genomics-study. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.8","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localisation of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120505300846000_51.4.318.9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120505300846000_51.4.318.10","unstructured":"Mettler FA Guibertau MJ . Essentials of Nuclear Medicine and Molecular Imaging. 7th ed. Elsevier; 2019:184."},{"key":"2023120505300846000_51.4.318.11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med."},{"key":"2023120505300846000_51.4.318.12","unstructured":"FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors. U.S. Food and Drug Administration website. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-diagnostic-imaging-agent-detect-rare-neuroendocrine-tumors. Published June 1, 2016. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.13","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120505300846000_51.4.318.14","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00259-019-04404-6","article-title":"Two decades of SPECT\/CT: the coming of age of a technology\u2014an updated review of literature evidence","volume":"46","author":"Israel","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023120505300846000_51.4.318.15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","article-title":"Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors","volume":"161","author":"Babic","year":"2017","journal-title":"Surgery."},{"key":"2023120505300846000_51.4.318.16","unstructured":"Hereditary phaeochromocytomas\/paraganglioma. Health New Zealand website. https:\/\/testguide.adhb.govt.nz\/EGuide\/?elv=1&name=Hereditary%20Phaeochromocytomas%2fParaganglioma&pn=3884&mn=1256&sd=3&ts=17e60db05d9. Updated March 22, 2021. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.17","unstructured":"What is paraganglioma? Pheopara Alliance website. https:\/\/pheopara.org\/education\/paraganglioma. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.18","first-page":"1","article-title":"Review of pediatric pheochromocytoma and paraganglioma","volume":"5","author":"Bolah","year":"2017","journal-title":"Front Pediatr."},{"key":"2023120505300846000_51.4.318.19","doi-asserted-by":"publisher","DOI":"10.4158\/EP161377.OR"},{"key":"2023120505300846000_51.4.318.20","unstructured":"New Zealand Guidelines Group (NZGG). Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. Manat\u016b Hauora Ministry of Health website. https:\/\/www.health.govt.nz\/publication\/suspected-cancer-primary-care-guidelines-investigation-referral-and-reducing-ethnic-disparities. Published September 2, 2009. Accessed August 17. 2023\/"},{"key":"2023120505300846000_51.4.318.21","unstructured":"Referral guidelines for suspected cancer. National Institute for Health and Clinical Excellence website. https:\/\/www.nice.org.uk\/guidance\/cg27. Published June 26, 2005. Accessed August 17, 2023."},{"key":"2023120505300846000_51.4.318.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186361"},{"key":"2023120505300846000_51.4.318.23","first-page":"205","article-title":"Pediatric paraganglioma: role of nuclear medicine imaging and therapeutic modalities","volume":"33","author":"Jha","year":"2018","journal-title":"Indian J Nucl Med."},{"key":"2023120505300846000_51.4.318.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03257.x"},{"key":"2023120505300846000_51.4.318.25","first-page":"1758835918793563","article-title":"Theranostics in neuroendocrine tumours: an appraisal of current and future agents","volume":"10","author":"Gupta","year":"2018","journal-title":"Ther Adv Med Oncol."},{"key":"2023120505300846000_51.4.318.26","first-page":"286","article-title":"Pediatric paraganglioma imaging with emphasis on nuclear medicine modalities","volume":"46","author":"Orevi","year":"2016","journal-title":"Semin Nucl Med."},{"key":"2023120505300846000_51.4.318.27","first-page":"E413","article-title":"New developments in the diagnosis and therapy of pheochromocytoma and paraganglioma: turning the tide on a rare and deadly disease","volume":"312","author":"Havekes","year":"2017","journal-title":"Am J Physiol Endocrinol Metab."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.123.265655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T13:30:41Z","timestamp":1701783041000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.123.265655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,5]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.2967\/jnmt.123.265655"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.123.265655","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}